Urology Practice最新文献

筛选
英文 中文
Editorial Commentary. 编辑评论。
IF 1.6
Urology Practice Pub Date : 2026-11-01 Epub Date: 2026-07-08 DOI: 10.1097/UPJ.0000000000001045
Richard J Boxer
{"title":"Editorial Commentary.","authors":"Richard J Boxer","doi":"10.1097/UPJ.0000000000001045","DOIUrl":"10.1097/UPJ.0000000000001045","url":null,"abstract":"","PeriodicalId":45220,"journal":{"name":"Urology Practice","volume":" ","pages":"651"},"PeriodicalIF":1.6,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148406130","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Editorial Commentary. 编辑评论。
IF 1.6
Urology Practice Pub Date : 2026-10-21 DOI: 10.1097/UPJ.0000000000001087
Tali Goldkorn, Jonathan Bergman
{"title":"Editorial Commentary.","authors":"Tali Goldkorn, Jonathan Bergman","doi":"10.1097/UPJ.0000000000001087","DOIUrl":"https://doi.org/10.1097/UPJ.0000000000001087","url":null,"abstract":"","PeriodicalId":45220,"journal":{"name":"Urology Practice","volume":" ","pages":"101097UPJ0000000000001087"},"PeriodicalIF":1.6,"publicationDate":"2026-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149239936","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Synchronous vs Staged Implantation of Inflatable Penile Prosthesis and Artificial Urinary Sphincter: A Nationwide Analysis of Infection and Revision Outcomes. 同步与分期植入充气阴茎假体和人工尿道括约肌:一项全国范围内的感染和修复结果分析。
IF 1.6
Urology Practice Pub Date : 2026-10-21 DOI: 10.1097/UPJ.0000000000001089
T Anne Zwaschka, Shufeng Li, Chiyuan Amy Zhang, Nicholas Sellke, Michael Scott, Michael L Eisenberg
{"title":"Synchronous vs Staged Implantation of Inflatable Penile Prosthesis and Artificial Urinary Sphincter: A Nationwide Analysis of Infection and Revision Outcomes.","authors":"T Anne Zwaschka, Shufeng Li, Chiyuan Amy Zhang, Nicholas Sellke, Michael Scott, Michael L Eisenberg","doi":"10.1097/UPJ.0000000000001089","DOIUrl":"10.1097/UPJ.0000000000001089","url":null,"abstract":"<p><strong>Introduction: </strong>The timing of implantation of inflatable penile prostheses (IPPs) and artificial urinary sphincters (AUSs) in patients requiring both devices remains controversial, with limited data comparing outcomes between synchronous dual implantation and staged procedures. The aim of this study was to assess the association between timing of IPP and AUS implantation and subsequent rates of device infection, revision, removal, or replacement using real-world administrative claims data.</p><p><strong>Methods: </strong>We performed a retrospective review using the Merative Marketscan research databases from 2007 to 2023. Men undergoing IPP and/or AUS implantation were identified using Current Procedural Terminology diagnosis and International Classification of Diseases procedure codes. Patients were stratified into 4 groups: synchronous dual implantation, solitary implant (IPP or AUS alone), and staged implantation (IPP or AUS first, followed by the other device). The primary composite outcome was device infection, revision, removal, or replacement. Patient demographics and comorbidities were collected. Kaplan-Meier survival analysis and multivariable Cox proportional hazards regression models were used to compare outcomes between groups, adjusting for relevant clinical variables.</p><p><strong>Results: </strong>We identified 18,426 men who underwent IPP placement, 4523 men who underwent AUS placement, and 659 men receiving both implants. Of these, 357 underwent concurrent IPP and AUS implantation, while 302 were implanted in a staged fashion. There was a higher risk of infection when placing 2 implants compared with placing 1 implant (HR 1.43 [1.13-1.80], <i>P</i> = .0032). However, synchronous placement of IPP and AUS was not associated with an increased risk of reoperation compared with staged placement (HR 1.50 [95% CI 0.87-2.58], <i>P</i> = .2).</p><p><strong>Conclusions: </strong>In the largest known cohort study of its kind, synchronous placement of IPP and AUS is not associated with higher rates of reoperation compared with staged placement, supporting the feasibility of concurrent implantation.</p>","PeriodicalId":45220,"journal":{"name":"Urology Practice","volume":" ","pages":"101097UPJ0000000000001089"},"PeriodicalIF":1.6,"publicationDate":"2026-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148945975","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Editorial Commentary. 编辑评论。
IF 1.6
Urology Practice Pub Date : 2026-10-21 DOI: 10.1097/UPJ.0000000000001091
Youssef Diab, Zaki Almallah, Omer A Raheem
{"title":"Editorial Commentary.","authors":"Youssef Diab, Zaki Almallah, Omer A Raheem","doi":"10.1097/UPJ.0000000000001091","DOIUrl":"https://doi.org/10.1097/UPJ.0000000000001091","url":null,"abstract":"","PeriodicalId":45220,"journal":{"name":"Urology Practice","volume":" ","pages":"101097UPJ0000000000001091"},"PeriodicalIF":1.6,"publicationDate":"2026-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149240013","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Editorial Commentary. 编辑评论。
IF 1.6
Urology Practice Pub Date : 2026-10-15 DOI: 10.1097/UPJ.0000000000001088
Michael Ernst
{"title":"Editorial Commentary.","authors":"Michael Ernst","doi":"10.1097/UPJ.0000000000001088","DOIUrl":"10.1097/UPJ.0000000000001088","url":null,"abstract":"","PeriodicalId":45220,"journal":{"name":"Urology Practice","volume":" ","pages":"101097UPJ0000000000001088"},"PeriodicalIF":1.6,"publicationDate":"2026-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149196985","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Advanced Practice Provider-Attributed Outpatient Visits and Procedures for Urologic Oncology Care in the United States. 美国泌尿外科肿瘤护理的高级实践提供者门诊访问量和程序。
IF 1.6
Urology Practice Pub Date : 2026-10-08 DOI: 10.1097/UPJ.0000000000001104
Aidan S Weitzner, Achyutha Kodavatikanti, Laura Alvim, Soum D Lokeshwar, Craig Cronin, Philipp Korn, Nirmish Singla
{"title":"Advanced Practice Provider-Attributed Outpatient Visits and Procedures for Urologic Oncology Care in the United States.","authors":"Aidan S Weitzner, Achyutha Kodavatikanti, Laura Alvim, Soum D Lokeshwar, Craig Cronin, Philipp Korn, Nirmish Singla","doi":"10.1097/UPJ.0000000000001104","DOIUrl":"https://doi.org/10.1097/UPJ.0000000000001104","url":null,"abstract":"<p><strong>Introduction: </strong>Integration of advanced practice providers (APPs) into the clinic setting holds potential to streamline care in urologic oncology. The impact of APP-attributed care in genitourinary oncology has not been well described. We sought to characterize national trends and the financial impact of APP-attributed outpatient visits and procedures within a privately insured urologic oncology population.</p><p><strong>Methods: </strong>We identified bladder, kidney, prostate, and testis cancer claims within the Merative MarketScan database from 2010 to 2023. Annual proportions of first-visit, overall, and select procedural APP-attributed claims were assessed descriptively. Comparisons by geographic status, urbanicity, insurance plan, and metastatic status were evaluated using chi-squared testing and multivariable modeling. Overall and out-of-pocket twelve-month health expenditures were assessed by whether first oncologic visit was APP-attributed.</p><p><strong>Results: </strong>There were 507,053 APP-attributed claims, increasing from 0.88% in 2010 to 3.38% in 2023. In adjusted analysis, later calendar year (OR: 1.1; p<0.001) had significantly higher odds of APP involvement, while residence within the Northeast (OR: 0.68; p<0.001) had significantly lower odds. APP-attributed first visits were associated with lower 12-month insurer-paid (SR: 0.81; p<0.001) and out-of-pocket (SR: 0.90; p<0.001) spending. Rates of APP-attributed cystoscopy and prostate biopsy remained modest.</p><p><strong>Conclusion: </strong>APP-attributed office and procedural outpatient visits are increasing, with variations in uptake present by practice region and patient characteristics. APP-attributed first visits were associated with lower 12-month insurer-paid spending without increased patient out-of-pocket spending.</p>","PeriodicalId":45220,"journal":{"name":"Urology Practice","volume":" ","pages":"101097UPJ0000000000001104"},"PeriodicalIF":1.6,"publicationDate":"2026-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149138715","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predicting Recurrence and Progression in Contemporary Patients with NMIBC Undergoing Blue Light Cystoscopy-Aided Transurethral Resection of Bladder Tumor. 预测蓝光膀胱镜辅助经尿道膀胱肿瘤切除术的当代NMIBC患者的复发和进展。
IF 1.6
Urology Practice Pub Date : 2026-10-05 DOI: 10.1097/UPJ.0000000000001103
Agustin Perez-Londoño, Jamil Almohtasib, Sumedh Kaul, Aaron Fleishman, Badrinath Konety, Kamal Pohar, Jeffrey M Holzbeierlein, John Taylor, Max Kates, Brian Willard, Jennifer M Taylor, Joseph C Liao, Hristos Z Kaimakliotis, Sima P Porten, Gary D Steinberg, Mark D Tyson, Yair Lotan, Siamak Daneshmand, Boris Gershman
{"title":"Predicting Recurrence and Progression in Contemporary Patients with NMIBC Undergoing Blue Light Cystoscopy-Aided Transurethral Resection of Bladder Tumor.","authors":"Agustin Perez-Londoño, Jamil Almohtasib, Sumedh Kaul, Aaron Fleishman, Badrinath Konety, Kamal Pohar, Jeffrey M Holzbeierlein, John Taylor, Max Kates, Brian Willard, Jennifer M Taylor, Joseph C Liao, Hristos Z Kaimakliotis, Sima P Porten, Gary D Steinberg, Mark D Tyson, Yair Lotan, Siamak Daneshmand, Boris Gershman","doi":"10.1097/UPJ.0000000000001103","DOIUrl":"https://doi.org/10.1097/UPJ.0000000000001103","url":null,"abstract":"<p><strong>Background: </strong>Although blue light cystoscopy (BLC) is recommended by clinical practice guidelines to improve cancer detection, predictive models for patients undergoing BLC are lacking. We therefore evaluated the associations of clinicopathologic features with recurrence and progression in a contemporary cohort of patients treated with BLC to develop a risk prediction model.</p><p><strong>Methods: </strong>We identified patients aged 18-89 years in the multi-institutional Blue Light Cystoscopy with Cysview Registry who underwent BLC-aided TURBT between 2014-2023. Associations of baseline characteristics with recurrence and progression were evaluated using Cox regression, and predictive models were developed using lasso regression.</p><p><strong>Results: </strong>1040 patients underwent BLC-TURBT. Tumor stage was Ta in 578 (56%), T1 in 166 (16%), and pure CIS in 190 (18%) patients. On multivariable analysis, HGTa (HR 1.60, 95%CI 1.10-2.35) and HGT1 (HR 1.94, 95%CI 1.25-3.02) tumors were associated with increased risk of recurrence. HGT1 (HR 12.4, 95%CI 4.52-34.0), HGTa (HR 3.08, 95% CI 1.03-9.18), pure CIS (HR 4.51, 95% CI 1.44-14.1), Ta+CIS (HR 4.98, 95%CI 1.17-21.1), and T1+CIS (HR 7.65, 95%CI 1.97-29.7) tumors, as well as lymphovascular invasion (HR 3.27, 95%CI 1.22-8.83) were associated with increased risk of progression. In contrast, adjuvant BCG was associated with decreased risk of progression (HR 0.40, 95%CI 0.22-0.72). Model discrimination was 0.64 for RFS and 0.73 for PFS.</p><p><strong>Conclusions: </strong>Using a multi-institutional cohort, we developed predictive models for recurrence and progression in patients undergoing BLC-TURBT. Although they require external validation, these models reflect to contemporary treatment paradigms and can inform personalized, risk-adapted management of NMIBC.</p>","PeriodicalId":45220,"journal":{"name":"Urology Practice","volume":" ","pages":"101097UPJ0000000000001103"},"PeriodicalIF":1.6,"publicationDate":"2026-10-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149116345","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
UROLOGISTS PERFORMING UROGYNECOLOGY AND RECONSTRUCTIVE PELVIC SURGERY PROCEDURES: THE IMPACT OF FELLOWSHIP TRAINING. 泌尿科医生执行泌尿妇科和骨盆重建手术程序:奖学金培训的影响。
IF 1.6
Urology Practice Pub Date : 2026-10-05 DOI: 10.1097/UPJ.0000000000001101
Dora Jericevic Schwartz, Rishika Gaddam, John Koo, Nirit Rosenblum, David Ginsberg, J Quentin Clemens, Benjamin M Brucker
{"title":"UROLOGISTS PERFORMING UROGYNECOLOGY AND RECONSTRUCTIVE PELVIC SURGERY PROCEDURES: THE IMPACT OF FELLOWSHIP TRAINING.","authors":"Dora Jericevic Schwartz, Rishika Gaddam, John Koo, Nirit Rosenblum, David Ginsberg, J Quentin Clemens, Benjamin M Brucker","doi":"10.1097/UPJ.0000000000001101","DOIUrl":"https://doi.org/10.1097/UPJ.0000000000001101","url":null,"abstract":"<p><strong>Introduction: </strong>Urogynecology and Reconstructive Pelvic Surgery (URPS) became an accredited fellowship in 2013. Our objective was to assess the landscape of URPS procedures performed by URPS fellowship-trained (FT) and non-FT urologists (NFT) since accreditation.</p><p><strong>Materials and methods: </strong>A retrospective cohort study of American Board of Urology case logs of urologists performing URPS procedures from January 2013 through August 2024 was conducted. The annual case volumes of FT and NFT urologists were compared. Multivariable mixed-effects Poisson regression models assessed the impact of covariates on annual case volume.</p><p><strong>Results: </strong>5,816 urologists (393 FT, 5,423 NFT) performing URPS procedures were included, with 513 FT and 5,818 NFT case log submissions. Compared to NFT, FT urologists were predominantly female (48% vs 13%, p<0.01), practiced in metropolitan areas (52% vs 23%, p<0.01) and academic settings (41% vs 7%, p<0.01). FT performed 24% of annual URPS cases on average, rising to 34% when excluding benign prostate hypertrophy (BPH) procedures. Modelling demonstrated that FT performed URPS cases at 4.2 times the annual rate of NFT (RR 4.2, 95% CI 3.6-4.6) on average, rising to 7.6 times when BPH was excluded (RR 7.6, 95% CI 6.7-8.6), controlling for other covariates. Independent of FT status, women performed non-BPH URPS at a 62% higher rate than men, with higher rates also seen among urologists that are younger, recertifying and outside the Northeast.</p><p><strong>Conclusions: </strong>Although NFT outnumber FT by 14 to one, FT performed eight times more non-BPH URPS cases annually on average and accounted for 34% of total non-BPH volume.</p>","PeriodicalId":45220,"journal":{"name":"Urology Practice","volume":" ","pages":"101097UPJ0000000000001101"},"PeriodicalIF":1.6,"publicationDate":"2026-10-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149116381","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ditching the Dipstick: Elevating US Urology Practice Efficiency and Guideline Compliance with Point-of-Care Quantitative Urinalysis. 抛弃试纸:提高美国泌尿外科实践效率和指南对即时定量尿液分析的依从性。
IF 1.6
Urology Practice Pub Date : 2026-10-05 DOI: 10.1097/UPJ.0000000000001102
Moustafa Kardjadj, Itoe P Penda, Roel Chavez
{"title":"Ditching the Dipstick: Elevating US Urology Practice Efficiency and Guideline Compliance with Point-of-Care Quantitative Urinalysis.","authors":"Moustafa Kardjadj, Itoe P Penda, Roel Chavez","doi":"10.1097/UPJ.0000000000001102","DOIUrl":"https://doi.org/10.1097/UPJ.0000000000001102","url":null,"abstract":"","PeriodicalId":45220,"journal":{"name":"Urology Practice","volume":" ","pages":"101097UPJ0000000000001102"},"PeriodicalIF":1.6,"publicationDate":"2026-10-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149116396","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Editorial Commentary. 编辑评论。
IF 1.6
Urology Practice Pub Date : 2026-09-25 DOI: 10.1097/UPJ.0000000000001085
Roger Dmochowski
{"title":"Editorial Commentary.","authors":"Roger Dmochowski","doi":"10.1097/UPJ.0000000000001085","DOIUrl":"10.1097/UPJ.0000000000001085","url":null,"abstract":"","PeriodicalId":45220,"journal":{"name":"Urology Practice","volume":" ","pages":"101097UPJ0000000000001085"},"PeriodicalIF":1.6,"publicationDate":"2026-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149041385","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书